NeutriSci International Inc. Logo

NeutriSci International Inc.

NU.V

(2.2)
Stock Price

0,01 CAD

-432.19% ROA

72.96% ROE

-1.61x PER

Market Cap.

892.120,00 CAD

-23.17% DER

0% Yield

-921% NPM

NeutriSci International Inc. Stock Analysis

NeutriSci International Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

NeutriSci International Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (66.88%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

The stock's low PBV ratio (-1.31x) suggests it's undervalued, making it an attractive opportunity for investors.

3 DER

The stock has a low debt to equity ratio (-23%), which means it has a small amount of debt compared to the ownership it holds

4 Revenue Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

5 Net Profit Growth

The net profit of this company has shown steady growth over the past three years, highlighting its positive financial trajectory and making it an appealing choice for potential investors.

6 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

7 ROA

The stock's ROA (-291.55%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

NeutriSci International Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

NeutriSci International Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Buy

NeutriSci International Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

NeutriSci International Inc. Revenue
Year Revenue Growth
2001 4.480
2002 2.386 -87.76%
2003 1.993 -19.72%
2004 101.438 98.04%
2005 61.995 -63.62%
2006 390.068 84.11%
2007 630.458 38.13%
2008 311.415 -102.45%
2009 488.172 36.21%
2010 218.482 -123.44%
2011 274.800 20.49%
2012 0 0%
2013 0 0%
2015 27.794 100%
2016 125.351 77.83%
2017 151.072 17.03%
2018 82.663 -82.76%
2019 96.538 14.37%
2020 74.572 -29.46%
2021 80.894 7.82%
2022 457.750 82.33%
2023 10.916 -4093.39%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

NeutriSci International Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2001 0
2002 0 0%
2003 264.367 100%
2004 260.011 -1.68%
2005 261.993 0.76%
2006 604.314 56.65%
2007 894.229 32.42%
2008 746.353 -19.81%
2009 598.228 -24.76%
2010 616.494 2.96%
2011 458.691 -34.4%
2012 0 0%
2013 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

NeutriSci International Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 511.174 100%
2009 447.123 -14.33%
2010 368.616 -21.3%
2011 424.686 13.2%
2012 153.431 -176.79%
2013 310.324 50.56%
2015 1.910.080 83.75%
2016 2.038.311 6.29%
2017 1.552.807 -31.27%
2018 1.716.000 9.51%
2019 1.419.813 -20.86%
2020 1.705.750 16.76%
2021 1.250.913 -36.36%
2022 600.233 -108.4%
2023 350.404 -71.3%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

NeutriSci International Inc. EBITDA
Year EBITDA Growth
2001 -15.323
2002 -18.079 15.24%
2003 -966.677 98.13%
2004 -2.481.389 61.04%
2005 -1.926.117 -28.83%
2006 -1.795.913 -7.25%
2007 -3.020.150 40.54%
2008 -1.780.797 -69.6%
2009 -1.224.819 -45.39%
2010 -1.346.159 9.01%
2011 -1.366.663 1.5%
2012 -153.431 -790.73%
2013 -310.324 50.56%
2015 -2.354.369 86.82%
2016 -2.570.295 8.4%
2017 -2.054.646 -25.1%
2018 -2.256.028 8.93%
2019 -1.646.414 -37.03%
2020 -1.916.971 14.11%
2021 -1.318.586 -45.38%
2022 -653.050 -101.91%
2023 -343.776 -89.96%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

NeutriSci International Inc. Gross Profit
Year Gross Profit Growth
2001 4.480
2002 2.386 -87.76%
2003 526 -353.61%
2004 -26.633 101.97%
2005 -21.199 -25.63%
2006 390.068 105.43%
2007 630.458 38.13%
2008 162.564 -287.82%
2009 163.948 0.84%
2010 107.319 -52.77%
2011 158.493 32.29%
2012 0 0%
2013 0 0%
2015 -19.926 100%
2016 25.416 178.4%
2017 -10.657 338.49%
2018 3.913 372.35%
2019 2.936 -33.28%
2020 -5.866 150.05%
2021 -20.547 71.45%
2022 -43.408 52.67%
2023 6.784 739.86%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

NeutriSci International Inc. Net Profit
Year Net Profit Growth
2001 -15.323
2002 -200.259 92.35%
2003 -1.009.216 80.16%
2004 -2.772.305 63.6%
2005 -1.983.111 -39.8%
2006 -1.807.329 -9.73%
2007 -3.042.328 40.59%
2008 -2.062.903 -47.48%
2009 -1.758.214 -17.33%
2010 -2.145.647 18.06%
2011 -2.493.061 13.94%
2012 7.905.504 131.54%
2013 -389.078 2131.86%
2015 -4.005.456 90.29%
2016 -2.564.830 -56.17%
2017 -2.122.269 -20.85%
2018 -2.382.899 10.94%
2019 -1.612.868 -47.74%
2020 -1.952.547 17.4%
2021 -1.572.197 -24.19%
2022 -770.694 -104%
2023 -388.988 -98.13%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

NeutriSci International Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2001 0
2002 -3 100%
2003 -2 0%
2004 -4 33.33%
2005 -2 -200%
2006 -1 0%
2007 -1 0%
2008 -1 0%
2009 -1 0%
2010 -1 0%
2011 -1 0%
2012 2 100%
2013 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

NeutriSci International Inc. Free Cashflow
Year Free Cashflow Growth
2001 -10.361
2002 -174.619 94.07%
2003 -970.026 82%
2004 -1.749.877 44.57%
2005 -1.525.938 -14.68%
2006 -2.024.414 24.62%
2007 -3.045.350 33.52%
2008 -1.755.082 -73.52%
2009 -1.183.194 -48.33%
2010 -1.267.811 6.67%
2011 -1.307.682 3.05%
2012 -1.154.666 -13.25%
2013 -291.489 -296.13%
2015 -2.113.903 86.21%
2016 -2.258.267 6.39%
2017 -1.514.892 -49.07%
2018 -2.073.610 26.94%
2019 -1.240.916 -67.1%
2020 -1.631.702 23.95%
2021 -1.148.254 -42.1%
2022 -170.845 -572.1%
2023 -5.897 -2797.15%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

NeutriSci International Inc. Operating Cashflow
Year Operating Cashflow Growth
2001 -10.361
2002 -174.619 94.07%
2003 -875.871 80.06%
2004 -1.719.142 49.05%
2005 -1.519.341 -13.15%
2006 -1.999.876 24.03%
2007 -2.991.108 33.14%
2008 -1.754.890 -70.44%
2009 -1.180.267 -48.69%
2010 -1.263.640 6.6%
2011 -1.306.618 3.29%
2012 -1.154.666 -13.16%
2013 -291.489 -296.13%
2015 -2.112.414 86.2%
2016 -2.256.554 6.39%
2017 -1.514.892 -48.96%
2018 -2.045.426 25.94%
2019 -1.240.916 -64.83%
2020 -1.521.223 18.43%
2021 -1.040.825 -46.16%
2022 -166.090 -526.66%
2023 -5.897 -2716.52%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

NeutriSci International Inc. Capital Expenditure
Year Capital Expenditure Growth
2001 0
2002 0 0%
2003 94.155 100%
2004 30.735 -206.34%
2005 6.597 -365.89%
2006 24.538 73.12%
2007 54.242 54.76%
2008 192 -28151.04%
2009 2.927 93.44%
2010 4.171 29.82%
2011 1.064 -292.01%
2012 0 0%
2013 0 0%
2015 1.489 100%
2016 1.713 13.13%
2017 0 0%
2018 28.184 100%
2019 0 0%
2020 110.479 100%
2021 107.429 -2.84%
2022 4.755 -2159.28%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

NeutriSci International Inc. Equity
Year Equity Growth
2001 337.554
2002 137.295 -145.86%
2003 1.063.902 87.1%
2004 -250.319 525.02%
2005 -487.780 48.68%
2006 -59.045 -726.12%
2007 -866.858 93.19%
2008 -2.792.146 68.95%
2009 -4.534.782 38.43%
2010 -6.636.562 31.67%
2011 -9.117.083 27.21%
2012 -705.484 -1192.32%
2014 928.713 175.96%
2015 726.980 -27.75%
2016 664.221 -9.45%
2017 131.387 -405.55%
2018 275.793 52.36%
2019 -156.237 276.52%
2020 -90.241 -73.13%
2021 -47.600 -89.58%
2022 -616.973 92.28%
2023 -914.774 32.55%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

NeutriSci International Inc. Assets
Year Assets Growth
2001 345.554
2002 171.580 -101.4%
2003 1.311.253 86.91%
2004 392.074 -234.44%
2005 354.635 -10.56%
2006 530.735 33.18%
2007 211.281 -151.2%
2008 182.839 -15.56%
2009 168.423 -8.56%
2010 91.245 -84.58%
2011 127.709 28.55%
2012 508.965 74.91%
2014 2.559.640 80.12%
2015 1.705.887 -50.05%
2016 1.139.950 -49.65%
2017 601.118 -89.64%
2018 553.546 -8.59%
2019 504.815 -9.65%
2020 528.277 4.44%
2021 819.512 35.54%
2022 331.427 -147.27%
2023 127.827 -159.28%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

NeutriSci International Inc. Liabilities
Year Liabilities Growth
2001 8.000
2002 34.285 76.67%
2003 247.351 86.14%
2004 642.393 61.5%
2005 842.415 23.74%
2006 589.780 -42.84%
2007 1.078.139 45.3%
2008 2.974.985 63.76%
2009 4.703.205 36.75%
2010 6.727.807 30.09%
2011 9.244.792 27.23%
2012 1.214.449 -661.23%
2014 1.630.927 25.54%
2015 978.907 -66.61%
2016 475.729 -105.77%
2017 469.731 -1.28%
2018 277.753 -69.12%
2019 661.052 57.98%
2020 618.518 -6.88%
2021 867.112 28.67%
2022 948.400 8.57%
2023 1.042.601 9.04%

NeutriSci International Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0
Price to Earning Ratio
-1.61x
Price To Sales Ratio
14.87x
POCF Ratio
-3.37
PFCF Ratio
-3.37
Price to Book Ratio
-0.98
EV to Sales
18.37
EV Over EBITDA
-2.33
EV to Operating CashFlow
-4.16
EV to FreeCashFlow
-4.16
Earnings Yield
-0.62
FreeCashFlow Yield
-0.3
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.02
Graham NetNet
-0.01

Income Statement Metrics

Net Income per Share
-0
Income Quality
0.48
ROE
0.73
Return On Assets
-4.32
Return On Capital Employed
0.63
Net Income per EBT
1
EBT Per Ebit
1.09
Ebit per Revenue
-8.42
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
7.31
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
-0.44
Operating Profit Margin
-8.42
Pretax Profit Margin
-9.21
Net Profit Margin
-9.21

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.72
Return on Tangible Assets
-4.32
Days Sales Outstanding
19.48
Days Payables Outstanding
3359.41
Days of Inventory on Hand
55.11
Receivables Turnover
18.74
Payables Turnover
0.11
Inventory Turnover
6.62
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
-0,01
Tangible Book Value per Share
-0.01
Shareholders Equity per Share
-0.01
Interest Debt per Share
0
Debt to Equity
-0.23
Debt to Assets
1.66
Net Debt to EBITDA
-0.44
Current Ratio
0.02
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-0.23
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
13330
Debt to Market Cap
0.24

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

NeutriSci International Inc. Dividends
Year Dividends Growth

NeutriSci International Inc. Profile

About NeutriSci International Inc.

NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada, the United States, Europe, Asia, and South America. It offers neuenergy, an energy tablet designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with LaSanta Botanicals, Nutritional High, and Naturally Splendid. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

CEO
Mr. Glen Rehman
Employee
0
Address
1600 – 609 Granville Street
Vancouver, V7Y 1C3

NeutriSci International Inc. Executives & BODs

NeutriSci International Inc. Executives & BODs
# Name Age
1 Mr. Thierry Sorhaitz
Vice President of Sales & Marketing
70
2 Ms. Jaycee Waters
Operations & Logistics Manager
70
3 Mr. Glen Rehman
Chief Executive Officer, President & Director
70
4 Mr. John Robert Chisholm
Chief Financial Officer
70

NeutriSci International Inc. Competitors